Recruiting Atrial Fibrillation Studies in Philadelphia
About Atrial Fibrillation Clinical Trials in Philadelphia
Atrial fibrillation (AFib) is the most common type of heart arrhythmia, causing an irregular and often rapid heartbeat. It significantly increases the risk of stroke, heart failure, and other complications. Treatment includes blood thinners, heart rate or rhythm control medications, and procedures like ablation.
There are currently 8 atrial fibrillation clinical trials recruiting participants in Philadelphia, PA. These studies are seeking a combined 7,918 participants. Research is being sponsored by University of Pennsylvania, McMaster University, Abbott Medical Devices and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Atrial Fibrillation Clinical Trials in Philadelphia — FAQ
Are there atrial fibrillation clinical trials in Philadelphia?
Yes, there are 8 atrial fibrillation clinical trials currently recruiting in Philadelphia, PA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Philadelphia?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Philadelphia research site will contact you about next steps.
Are clinical trials in Philadelphia free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Philadelphia studies also compensate for your time and travel.
What atrial fibrillation treatments are being tested?
The 8 active trials in Philadelphia are testing new therapies including novel drugs, biologics, and treatment approaches for atrial fibrillation.
Data updated July 16, 2026 from ClinicalTrials.gov